Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

Guanylate Cyclase

  • Karl-Wilhelm Koch
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_243

Synonyms

Historical Background

The concept of second messenger molecules in hormone signal transduction was developed in the 1950s by Earl W. Sutherland describing the cyclic nucleotide adenosine 3′, 5′-cyclic monophosphate (cAMP) as an intracellular messenger molecule. The main features of this concept are the binding of a hormone to the extracellular site of a transmembrane receptor protein which triggers an intracellular response mediated by a second messenger molecule (e.g., cAMP). Shortly after cAMP was discovered as second messenger in hormone signaling, another cyclic nucleotide abbreviated cGMP (guanosine 3′, 5′-cyclic monophosphate) was first detected in rat urine (Ashman et al. 1963) and soon after was found in a variety of other tissues and biological samples. Every second messenger system requires the presence of synthesizing and degrading enzymes. For cyclic purine monophosphates these are adenylate and guanylate cyclases and specific forms of...

This is a preview of subscription content, log in to check access.

References

  1. Ashman DF, Lipton R, Melicow MM, Price TD. Isolation of adenosine 3′,5′-monophosphate and guanosine3′,5′-monophosphate from rat urine. Biochem Biophys Res Commun. 1963;11:330–4.PubMedCrossRefGoogle Scholar
  2. Baker DA, Kelly JM. Structure, function and evolution of microbial adenylyl and guanylyl cyclases. Mol Microbiol. 2004;52:1229–42.PubMedCrossRefGoogle Scholar
  3. Beavo JA, Brunton LL. Cyclic nucleotide research – still expanding after half a century. Nat Rev Mol Cell Biol. 2002;3:710–8.PubMedCrossRefGoogle Scholar
  4. Garthwaite J. New insight into the functioning of nitric oxide-receptive guanylyl cyclase: physiological and pharmacologicalimplications. Mol Cell Biochem. 2010;334:221–32.PubMedCrossRefGoogle Scholar
  5. Koch KW, Duda T, Sharma RK. Ca 2+-modulated vision-linked ROS-GC guanylate cyclase transduction machinery. Mol Cell Biochem. 2010;334:105–15.PubMedCrossRefGoogle Scholar
  6. Kots AY, Martin E, Sharina IG, Murad F. A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases. In: Schmidt HHHW et al., editors. cGMP: generators, effectors and therapeutic implications, handbook of experimental pharmacology, vol. 191. Berlin/Heidelberg: Springer; 2009. p. 1–14.CrossRefGoogle Scholar
  7. Kuhn M. Molecular physiology of membrane guanylyl cyclase receptors. Physiol Rev. 2016;96:751–804.PubMedCrossRefGoogle Scholar
  8. Lin JE, Li P, Pitari GM, Schulz S, Waldman SA. Guanylyl cyclase C in colorectal cancer: susceptibility gene and potential therapeutic target. Future Oncol. 2009;5:509–22.PubMedPubMedCentralCrossRefGoogle Scholar
  9. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepnik KP, Waldman SA. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev. 2000;52:375–413.PubMedGoogle Scholar
  10. Martel G, Hamet P, Trembly J. Central role of guanylyl cyclase in natriuretic peptide signaling in hypertension and metabolic syndrome. Mol Cell Biochem. 2010;334:53–65.PubMedCrossRefGoogle Scholar
  11. Ortiz CO, Etchberger JF, Posy SL, Frokjaer-Jensen C, Lockery S, Honig B, Hobert O. Searching for neuronal left/right asymmetry: genomewide analysis of nematode receptor-type guanylyl cyclases. Genetics. 2006;173:131–49.PubMedPubMedCentralCrossRefGoogle Scholar
  12. Potter LR, Yoder AR, Flora DR, Antos LK, Dickey DM. Natriuretic peptides: their structures, receptors, physiological functions and therapeutic applications. In: Schmidt HHHW et al., editors. cGMP: generators, effectors and therapeutic implications, handbook of experimental pharmacology, vol. 191. Berlin/Heidelberg: Springer; 2009. p. 341–66.CrossRefGoogle Scholar
  13. Rätscho N, Scholten A, Koch KW. Diversity of guanylate cyclases in teleost fishes. Mol Cell Biochem. 2010;334:207–14.PubMedCrossRefGoogle Scholar
  14. Sharma RK. Membrane guanylate cyclase is a beautiful signal transduction machine: overview. Mol Cell Biochem. 2010;334:3–36.PubMedCrossRefGoogle Scholar
  15. Sharma RK, Duda T. Odorant-linked ROS-GC subfamily membrane guanylate cyclase transduction system. Mol Cell Biochem. 2010;334:181–9.PubMedCrossRefGoogle Scholar
  16. Tamura N, Chrisman TD, Garbers DL. The regulation and physiological roles of the guanylyl cyclase receptors. Endocrine J. 2001;48:611–34.CrossRefGoogle Scholar
  17. Wang HY, Malbon CC. Wnt-frizzled signaling to G-protein-coupled effectors. Cell Mol Life Sci. 2004;61:69–75.PubMedCrossRefGoogle Scholar
  18. Zufall F, Munger SD. Receptor guanylyl cyclases in mammalian olfactory function. Mol Cell Biochem. 2010;334:191–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of NeurosciencesUniversity of OldenburgOldenburgGermany